I managed to see the $0.77 EPS figure myself but that was applying the normalized 2020 profit to the calculation (profit after allowing for abnormal items). The statutory after tax profit for 2020 of $42m provides an EPS of $0.519 as per published result.
The predicted result of $78m to $80m would provide EPS of around $0.97 according to my arithmetic. With that in mind, given that they normally provide a payout around 80% of the EPS, it may be reasonable to think about a final dividend of $0.40 for a full year dividend of $0.80.
A bit of estimation in there. They may hold some of that back if they're not comfortable about obtaining a similar result in 2022.
- Forums
- ASX - By Stock
- NCK
- News: NCK Nick Scali Expects FY NPAT Of $78 Mln-$80 Mln
News: NCK Nick Scali Expects FY NPAT Of $78 Mln-$80 Mln, page-7
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NCK (ASX) to my watchlist
(20min delay)
|
|||||
Last
$16.07 |
Change
0.020(0.12%) |
Mkt cap ! $1.369B |
Open | High | Low | Value | Volume |
$16.12 | $16.24 | $15.99 | $2.726M | 169.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 639 | $16.00 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$16.09 | 7386 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 639 | 16.000 |
2 | 640 | 15.980 |
1 | 639 | 15.970 |
1 | 2011 | 15.960 |
1 | 639 | 15.950 |
Price($) | Vol. | No. |
---|---|---|
16.100 | 639 | 1 |
16.120 | 639 | 1 |
16.130 | 639 | 1 |
16.150 | 639 | 1 |
16.180 | 1906 | 2 |
Last trade - 16.10pm 10/10/2024 (20 minute delay) ? |
Featured News
NCK (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, MD & CEO
James Graham
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online